Pegaferon in hepatitis C: Results of a Multicenter Study

BACKGROUND Chronic hepatitis C (CHC) is a major contributor to cirrhosis and hepatocellular carcinoma and major global public health problem that causes mortality in both developed and developing countries.For the past decade, treatment with pegylated interferon (peg interferon α) and ribavirin (RBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbari, Hossain, Zamani, Farhad, Hatami, Khadijeh, Sheikholeslami, Arghavan, Fakharzadeh, Elham, Shahzamani, Kiana, Zamini, Hedye, Merat, Shahin, Malekzadeh, Reza, Sharfi, Amir Houshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154913/
https://www.ncbi.nlm.nih.gov/pubmed/25197541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154913/
https://www.ncbi.nlm.nih.gov/pubmed/25197541

Ejemplares similares